(S (NP (NP (DT The) (JJ fundamental) (NN goal)) (PP (IN of) (NP (JJ generative) (NN drug) (NN design)))) (VP (VBZ is) (S (VP (TO to) (VP (VB propose) (NP (NP (JJ optimized) (NNS molecules)) (SBAR (WHNP (WDT that)) (S (VP (VBP meet) (NP (JJ predefined) (UCP (NN activity) (, ,) (NN selectivity) (, ,) (CC and) (JJ pharmacokinetic)) (NNS criteria)))))))))) (. .))
(S (PP (IN Despite) (NP (JJ recent) (NN progress))) (, ,) (NP (PRP we)) (VP (VBP argue) (SBAR (IN that) (S (NP (VBG existing) (JJ generative) (NNS methods)) (VP (VBP are) (ADJP (VBN limited) (PP (IN in) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (ADVP (RB favourably)) (VB shift) (NP (NP (DT the) (NNS distributions)) (PP (IN of) (NP (JJ molecular) (NNS properties)))) (PP (IN during) (NP (NN optimization))))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB instead)) (VP (VBD propose) (NP (NP (DT a) (JJ novel) (NNP Reinforcement) (NNP Learning) (NN framework)) (PP (IN for) (NP (JJ molecular) (NN design))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT an) (NN agent)) (VP (VBZ learns) (S (VP (TO to) (VP (ADVP (RB directly)) (VB optimize) (PP (IN through) (NP (NP (DT a) (NN space)) (PP (IN of) (NP (JJ synthetically-accessible) (JJ drug-like) (NNS molecules))))))))))))) (. .))
(S (NP (DT This)) (VP (VP (VBZ becomes) (ADJP (JJ possible)) (PP (IN by) (S (VP (VBG defining) (NP (NP (NNS transitions)) (PP (IN in) (NP (PRP$ our) (NNP Markov) (NNP Decision) (NNP Process)))) (PP (IN as) (NP (NN chemical) (NNS reactions))))))) (, ,) (CC and) (VP (VBZ allows) (S (NP (PRP us)) (VP (TO to) (VP (VB leverage) (NP (JJ synthetic) (NNS routes)) (PP (IN as) (NP (DT an) (JJ inductive) (NN bias)))))))) (. .))
(S (NP (PRP We)) (VP (VBP validate) (NP (PRP$ our) (NN method)) (PP (IN by) (S (VP (VBG demonstrating) (SBAR (SBAR (IN that) (S (NP (PRP it)) (VBZ outperforms) (NP (VBG existing) (PP (JJ state-of) (NP (DT the) (NN art))) (VBZ approaches)) (PP (IN in) (NP (NP (DT the) (NN optimization)) (PP (IN of) (NP (JJ pharmacologically-relevant) (NNS objectives))))))) (, ,) (SBAR (IN while) (S (NP (NP (NNS results)) (PP (IN on) (NP (JJ multi-objective) (NN optimization) (NNS tasks)))) (VP (VBP suggest) (NP (NP (VBN increased) (NN scalability)) (PP (TO to) (NP (JJ realistic) (JJ pharmaceutical) (NN design) (NNS problems)))))))))))) (. .))
